Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05358535 · ClinicalTrials.gov registry record · Phase 3
Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
A Phase 3 study of Anesthesia and Anesthesia Complication, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05358535: Recruiting Phase 3 study of Anesthesia and Anesthesia Complication, sponsored by University of Texas Southwestern Medical Center.
NCT05358535 is a Phase 3 study of Anesthesia and Anesthesia Complication that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 200 participants, below the 109,407-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05358535, a Phase 3 study of Anesthesia and Anesthesia Complication, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).
Primary Outcome
Time weighted average mean arterial pressure (every 15 minutes calculate average mean arterial pressure for that interval, then end of case calculate mean of all those means for the entire case)
Conditions Studied
Interventions
- DRUG Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2)
- DRUG Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7)
Study Locations (1)
Texas
- Clements University Hospital - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2027-03 |
| Phase | Phase 3 |
What NCT05358535 shows while recruiting
NCT05358535 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 109,407-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2) is the first listed.
NCT05358535 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05358535 about?
NCT05358535 is a clinical study titled "Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)". The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% ...
What is the current status of trial NCT05358535?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2022-09-19. Estimated completion is 2027-03.
What conditions does trial NCT05358535 study?
This clinical trial studies the following conditions: Anesthesia, Anesthesia Complication, Anesthesia; Adverse Effect, Anesthesia; Reaction, Propofol Adverse Reaction.
What interventions are being tested in trial NCT05358535?
The interventions under investigation include: Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2) (DRUG), Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7) (DRUG).
Who is sponsoring clinical trial NCT05358535?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05358535 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05358535's enrollment target sits among peer trials
200 12th of 57 higher than 46 of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
A Study to Compare the Long-term Outcomes After Two Different Anaesthetics
ACTIVE NOT RECRUITING · Phase 3
-
Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables
COMPLETED · Phase 3
-
Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children
COMPLETED · Phase 3
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI